ChapterDx Colorectal and Lung Cancer NGS Kit 

Sequencing and analyzing 15 genes and over 400 hotspot mutations in a single- tube with high accuracy. Expandable to larger gene panels.

Genes: AKT1, ALK, BRAF, CTNNB1, EGFR, ERBB2, HRAS, KIT, KRAS, MAP2K1, MET, NRAS, PDGFRA, PIK3CA and TP53

Description

ChapterDx colorectal and lung cancer assay is a customized NGS-based panel that sequences and analyzes 15 genes related to colorectal and lung cancer, providing more precise information for companion diagnostic and personalized treatment. The assay detects over 400 hotspot mutations and has been clinically validated. Due to ChapterDx innovative proprietary technology, the assay can be customized to analyze larger gene panels and cover more hotspot mutations. The kit includes a data analysis software. 

Technology

The ChapterDx multiplex gene enrichment method is a proprietary technology that can be tailored and custom-made for enrichment of highly multiplex cancer gene panels in a single tube. It has high accuracy, sensitivity and specificity. 

Features

- Single-tube amplification

- 15 genes and over 400 hotspot mutations

- Accurate mutation detection

- High sensitivity and specificity

- Clinically validated

- Based on ChapterDx proprietary technology

- Expandable to larger gene panels

- Cost-efficient

Cancer Gene Panel

Colorectal and Lung Cancer Gene Panel

Cat No./ Size     C7735A /50 rxns (including 50 indexing)

                         

                          C7735B /100 rxns (including 100 indexing)

                          C7735C /200 rxns (including 200 indexing)

For Research Use Only (RUO)